Catalyst Wire Dossier Catalyst Wire Dossier

Risperidone 1 mg orally-disintegrating tablet

Risperidone · Ranbaxy Laboratories Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Risperidone 1 mg orally-disintegrating tablet, covering 2010-10-18 to 2010-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions [NA]

See pricing